• SBC Medical Group Holdings reported revenue of USD 43.06 million, down 9.02% year over year, while net income attributable to shareholders fell 47.41% to USD 11.31 million.
• Operating income dropped 26.78% to USD 17.72 million, as cost of revenues climbed 32.5% to USD 12.71 million.
• Other income slid 84.32% to USD 1.14 million, reflecting no gain on redemption of life insurance policies versus the prior-year period.
• Net cash provided by operating activities rose to USD 9.23 million from USD 1.93 million a year earlier, while cash and cash equivalents ended at USD 167.31 million.
• In April 2026, CEO sold 3,565,000 shares in a secondary offering priced at USD 3.25 per share; company received no proceeds and recorded about USD 1.4 million in transaction costs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SBC Medical Group Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-222737), on May 14, 2026, and is solely responsible for the information contained therein.